Setting Priorities for Preparing Product Risk Characterizations
Below are factors to consider when categorizing chemicals as “high priority” for
completing risk characterizations (and subsequently developing associated risk
management recommendations). They should be applied in light of the
circumstances of each individual company and region. This approach also
provides companies flexibility so that they can make expert judgments about the
appropriate criteria required for their product lines, based on the screening
of relevant available hazard information as well as information on potential
exposure and risk associated with the chemical and its use by the respective
company and value chain. Companies can set their priorities from a comprehensive point of view,
taking these factors and other business considerations into account.
Primary Considerations For Categorizing
Chemicals As “High Priority“
·
Chemicals
with testing and/or risk evaluation work already completed or underway in
response to current or impending regulatory scrutiny (e.g., Canadian DSL, EU
Regulation of existing chemical substances, EU REACH);
·
Categories of
chemicals of particular concern under national or regional
regulatory programs, such as those listed as known carcinogens, mutagens, or
substances that are toxic to reproduction;
·
Chemicals listed
as candidates under the Stockholm Convention
(Persistent Organic Pollutants) or the Rotterdam Convention
(Prior Informed Consent);
·
Chemicals
restricted by other national or regional regulations or international
conventions.
Other Relevant Factors That
May Be Considered Include, But Are Not Limited To:
·
Whether
the chemical could be classified as Persistent, Bioaccumulative and Toxic (PBT);
·
Whether
and to what extent the chemical has potential for (significant) human exposure,
especially when children and other sensitive subpopulations could be
impacted. For example, such chemicals
might include those:
-
used in products
used by children;
-
used in consumer
products, medical devices, drugs or cosmetics, particularly where such products
are not regulated under a separate legal regime;
·
Whether
and to what extent the chemical has a potential for significant environmental
exposure when these chemicals are not regulated under a specific regime;
·
Whether
the chemical presents a significant acute hazard (e.g., highly flammable,
corrosive, reactive, etc.);
·
Whether
the chemical is a high production volume chemical (1,000 tons production per
year);
·
Whether
and to what extent the chemical is a focus of broader or increasing societal
concern;
·
Whether
there are attributes of the value chain for a particular chemical that could
raise significant concern (e.g., customers are very numerous or generally lack
sophistication and competency in managing chemicals, or they do not have adequate product
stewardship practices in place);
·
Whether
a company wants to make a chemical “high priority” for business or other
purposes (e.g., a new product or an existing product in a new application).
Key Steps in Risk Characterization
and Risk Management
Gathering Product Information:
The first step is
to gather available, relevant hazard and potential exposure information. This
information is used to characterize risks that may occur during handling,
transport and use. The range of
information sources can vary widely, including e.g., supplier (Material) Safety Data Sheets and labels, predefined
regulatory criteria, and published reports.
Relevant,
available information on usage, hazard and exposure should be gathered to help understand
the key health and environmental effects of the chemicals produced,
distributed, used, recycled or disposed. This
includes hazard and possible exposure information adequate to conduct a product
risk characterization. Such information may include:
·
Major
components and/or impurities;
·
Physical
and chemical characteristics;
·
Potential
human health hazards;
·
Potential
environmental hazards;
·
Uses,
functions and applications of products;
·
Production
volume ranges;
·
General
descriptions of potential exposure pathways;
·
Potential
misuses, as reasonably foreseeable, or as known from customers, consumers or
authorities.
Sources of such information
may include, although are not limited to:
·
(Material) Safety
Data Sheets and labels for raw materials used to manufacture the product;
·
Dialogue with
suppliers of raw materials;
·
Governmental regulatory/sources
e.g. OECD/SIDS dossiers, ORATS (Online European Risk Assessment Tracking
System);
·
Databases e.g.
IRIS, ESIS (European Chemical Substance Information System);
·
Reference books.
Chemical Definition—Identification of
Chemical/Application
In the initial
step, a company identifies its chemicals and their uses/applications in
commerce. Risk characterization results
and risk management implementation may differ for the same chemical depending
on its specific use/application. This provides a more flexible risk management
approach in which actions to prevent or control risks should be tailored to an application
rather than arbitrarily prescribed for a chemical in all applications.
Establish Knowledgebase
In the
development of the knowledge base, existing relevant available information on
the chemical and its applications should
be gathered. Items to consider may include:
·
Lifecycle;
·
Product
characterization (including physicochemical properties);
·
Hazard
and exposure information;
·
Current risk management/management measures;
·
Regulatory restrictions;
·
Public
concern;
·
Identification
of screening/priority-setting criteria (the criteria against which the outcomes
of the risk characterization work will be measured. There may be cases in which regulatory
mandated criteria exist for certain endpoints).
Conduct Risk Characterization
Hazard Evaluation
Hazard is an intrinsic property of a chemical and can be assessed
independent of its use or application. Hazard evaluation addresses the kinds of
adverse health and environmental effects that have been observed, the level of
certainty, the severity, the significance of the effect, and the quantitative relationship between
exposure and effects (often expressed as “dose-response” curve).
Information may be derived from laboratory testing of
physico-chemical, toxicological or
ecotoxicological properties, from data on similar chemicals, QSAR
(Structure Activity Relationships), studies, literature, experience, etc.
Exposure Evaluation
Consider potential exposures to humans and the environment from
the production, distribution, use, and disposal or recycling of a chemical.
Exposure is a determinant of chemical-induced human and ecological
effects and is a key component of the risk characterization. Exposure evaluation considers the magnitude,
frequency, duration, and route of potential or actual human and environmental
exposures. It also considers the nature,
size and constitution of the potentially exposed population. Important factors in characterizing exposure
include conditions of packaging, transportation, storage, use, reuse, and
disposal.
Information may be derived from known exposure categories or
scenarios, workplace measurements, air and water sampling, etc.
Is Information Sufficient to
Complete a Risk Characterization?
This preliminary risk characterization should provide an
understanding of the nature, magnitude and probability of a potential adverse
health or environmental effect. It
should also include uncertainties associated with the exposure and hazard
evaluations. Additional risk
characterization information may be obtained by comparing the chemical to a
similar one.
Results of the preliminary risk characterization should be weighed
against the organization’s identified screening and/or priority criteria to
determine if additional risk characterization is needed. If so, resources should be directed first at
those products or applications that had the highest risks identified through
the preliminary characterization process.
Decision Point
If there is sufficient information to complete a risk
characterization, proceed to the Risk Management step under ‘DO’.
If there is insufficient information to complete a risk
characterization, additional, relevant hazard or exposure information may be
needed. This step should be repeated until you are satisfied that a meaningful
product risk characterization can be undertaken.
Other Influences
And Issues Affecting Product Stewardship Requirements
·
Organization policies;
·
Clear understanding (mapping) of the
different value chains through which the organization’s chemicals pass;
·
Organization’s processes for procuring raw
materials and marketing and selling its chemicals;
·
Relevant technical standards;
·
Results of audits;
·
Constructive opinions and views of
stakeholders which may include, but not be limited to, employee feedback, correspondence from
the public or non-governmental environment organizations (NGOs), investors
comments, requirements from customers, insurance audit reports and surveys and
questionnaires.
Examples of Product Stewardship Practices And
Possible Associated Internal Metrics
A.
Management – Setting Policies and Objectives
and Planning
Practices
·
Written corporate
policies that discuss the commitment of management to achieving the objectives
of Responsible Care®, including product stewardship, and the
communication of those polices throughout the company;
·
Written corporate
policies that address core values including a commitment to Responsible Care
and product stewardship, and communication of those values in and outside the
company;
·
A written set of
objectives to be accomplished by the company under Responsible Care and product
stewardship, as well as a plan to achieve those objectives;
·
An organizational
infrastructure to achieve the objectives of product stewardship, i.e.,
employees that have product stewardship performance as part of their job
responsibilities;
·
Involvement of
high level management in the review and tracking of company performance toward
implementation of Responsible Care and product stewardship.
Possible
Internal Metrics or Milestones
·
Written corporate
policies addressing a commitment to Responsible Care and product stewardship
are in place;
·
Written
objectives and plans for product stewardship implementation;
·
Company resources
dedicated to implementing Responsible Care and product stewardship are in place;
·
A mechanism to
track company performance toward implementing Responsible Care and product
stewardship are in place.
No comments:
Post a Comment